DATSCAN

This brand name is authorized in United States. It is also authorized in Austria, Croatia, Cyprus, Estonia, France, Hong Kong SAR China, Ireland, Japan, Lithuania, Poland, Romania, Singapore, Spain, Turkey, UK.

Active ingredients

The drug DATSCAN contains one active pharmaceutical ingredient (API):

1	Ioflupane ¹²³I UNII 3MM99T8R5Q - IOFLUPANE I-123
	Ioflupane ¹²³I is a radiopharmaceutical indicated for striatal dopamine transporter visualization using single photon emission computed tomography (SPECT) brain imaging to assist in the evaluation of adult patients with suspected Parkinsonian syndromes (PS).
	Read more about Ioflupane ¹²³I

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DATSCAN Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V09AB03	Iodine ioflupane (123I)	V Various → V09 Diagnostic radiopharmaceuticals → V09A Central nervous system → V09AB Iodine (123I) compounds
Discover more medicines within V09AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1128967, 1130397
ES	Centro de información online de medicamentos de la AEMPS	00135001, 00135002
FR	Base de données publique des médicaments	69236394
GB	Medicines & Healthcare Products Regulatory Agency	394164, 394167
HK	Department of Health Drug Office	65608
JP	医薬品医療機器総合機構	4300451G1021
LT	Valstybinė vaistų kontrolės tarnyba	1011685, 1027869
PL	Rejestru Produktów Leczniczych	100124992
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66156001, W66156002
SG	Health Sciences Authority	15325P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699360730348
US	FDA, National Drug Code	17156-210